Coral Laboratories Limited (BOM:524506)
422.85
-16.35 (-3.72%)
At close: Jan 21, 2026
Coral Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 889.77 | 1,150 | 836.6 | 781.19 | 756.11 | 965.67 | Upgrade |
| 889.77 | 1,150 | 836.6 | 781.19 | 756.11 | 965.67 | Upgrade | |
Revenue Growth (YoY) | -19.73% | 37.47% | 7.09% | 3.32% | -21.70% | 36.82% | Upgrade |
Cost of Revenue | 413.7 | 540.65 | 381.04 | 467.73 | 408.04 | 521.98 | Upgrade |
Gross Profit | 476.07 | 609.4 | 455.57 | 313.46 | 348.07 | 443.7 | Upgrade |
Selling, General & Admin | 147.46 | 151.46 | 121.4 | 112.93 | 117.5 | 125.91 | Upgrade |
Other Operating Expenses | 163.77 | 191.88 | 168.3 | 157.99 | 144.69 | 155.13 | Upgrade |
Operating Expenses | 330.38 | 363.45 | 309.46 | 292.73 | 282.1 | 300.87 | Upgrade |
Operating Income | 145.69 | 245.95 | 146.11 | 20.73 | 65.97 | 142.83 | Upgrade |
Interest Expense | -2.19 | -0.98 | -0 | -3.39 | -1.41 | -0.43 | Upgrade |
Interest & Investment Income | 48.39 | 48.39 | 33.56 | 17.87 | 17.49 | 20.45 | Upgrade |
Currency Exchange Gain (Loss) | 14.88 | 14.88 | 9.51 | 32.35 | 13.83 | 0.01 | Upgrade |
Other Non Operating Income (Expenses) | 30.67 | 24.15 | 19.78 | 14.31 | 13.09 | 13.08 | Upgrade |
EBT Excluding Unusual Items | 237.45 | 332.4 | 208.96 | 81.88 | 108.96 | 175.94 | Upgrade |
Other Unusual Items | -4.47 | -7.7 | -1.64 | 0.38 | 9.59 | 0.19 | Upgrade |
Pretax Income | 232.98 | 324.7 | 207.32 | 82.26 | 118.56 | 176.12 | Upgrade |
Income Tax Expense | 59.45 | 83.15 | 49.43 | 17.81 | 28.1 | 40.58 | Upgrade |
Net Income | 173.53 | 241.56 | 157.89 | 64.45 | 90.46 | 135.55 | Upgrade |
Net Income to Common | 173.53 | 241.56 | 157.89 | 64.45 | 90.46 | 135.55 | Upgrade |
Net Income Growth | -24.97% | 52.99% | 144.97% | -28.75% | -33.27% | 90.10% | Upgrade |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 | Upgrade |
EPS (Basic) | 48.57 | 67.61 | 44.19 | 18.04 | 25.32 | 37.94 | Upgrade |
EPS (Diluted) | 48.57 | 67.61 | 44.19 | 18.04 | 25.32 | 37.94 | Upgrade |
EPS Growth | -24.97% | 52.99% | 144.97% | -28.75% | -33.27% | 90.10% | Upgrade |
Free Cash Flow | 73.26 | -41.67 | -64.56 | 107.2 | 5.35 | -4.29 | Upgrade |
Free Cash Flow Per Share | 20.51 | -11.66 | -18.07 | 30.01 | 1.50 | -1.20 | Upgrade |
Dividend Per Share | - | 1.500 | 2.000 | - | - | - | Upgrade |
Dividend Growth | - | -25.00% | - | - | - | - | Upgrade |
Gross Margin | 53.51% | 52.99% | 54.45% | 40.13% | 46.03% | 45.95% | Upgrade |
Operating Margin | 16.37% | 21.39% | 17.46% | 2.65% | 8.72% | 14.79% | Upgrade |
Profit Margin | 19.50% | 21.00% | 18.87% | 8.25% | 11.96% | 14.04% | Upgrade |
Free Cash Flow Margin | 8.23% | -3.62% | -7.72% | 13.72% | 0.71% | -0.45% | Upgrade |
EBITDA | 164.71 | 265.92 | 165.82 | 42.45 | 85.75 | 162.48 | Upgrade |
EBITDA Margin | 18.51% | 23.12% | 19.82% | 5.43% | 11.34% | 16.83% | Upgrade |
D&A For EBITDA | 19.02 | 19.97 | 19.71 | 21.72 | 19.78 | 19.65 | Upgrade |
EBIT | 145.69 | 245.95 | 146.11 | 20.73 | 65.97 | 142.83 | Upgrade |
EBIT Margin | 16.37% | 21.39% | 17.46% | 2.65% | 8.72% | 14.79% | Upgrade |
Effective Tax Rate | 25.52% | 25.61% | 23.84% | 21.65% | 23.70% | 23.04% | Upgrade |
Revenue as Reported | 987.38 | 1,241 | 902.93 | 850.14 | 804.24 | 1,003 | Upgrade |
Advertising Expenses | - | 4.09 | 9.41 | 1.6 | 5.24 | 24.09 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.